Content Type: Article

  • Compulsory Licensing as a Legal Means to Avoid Shortages of Coronavirus Vaccines?

    Compulsory Licensing as a Legal Means to Avoid Shortages of Coronavirus Vaccines?

    ARTICLE

    Compulsory Licensing as a Legal Means to Avoid Shortages of Coronavirus Vaccines?

    October 2020

    Read time: 2 min

    Key takeaways
    Overview

    Dr. Boris Uphoff and Daniel Reich authored the article “Compulsory Licensing as a Legal Means to Avoid Shortages of Coronavirus Vaccines?”, featured in Betriebs-Berater, issue 44 in October, 2020.

    In depth
    Authors

    Dr. Boris Uphoff

    Partner

    Munich, Düsseldorf

    More insights

  • Eye Don’t: No Counterfeiting without Likelihood of Confusion

    Eye Don’t: No Counterfeiting without Likelihood of Confusion

    ARTICLE

    Eye Don’t: No Counterfeiting without Likelihood of Confusion

    October 26, 2020

    Read time: 1 min

    Key takeaways
    Overview

     

     

    In depth
    Authors

    Sarah Bro

    Partner

    Orange County, Los Angeles

    More insights

  • Antitrust M&A Snapshot

    Antitrust M&A Snapshot

    ARTICLE

    Antitrust M&A Snapshot

    October 2020

    Read time: 3 min

    Key takeaways
    Overview

    In the United States, mergers and acquisitions appear to be bouncing back after a muted start to the year due to COVID-19. Hart-Scott-Rodino (HSR) filings in Q3 2020 were up significantly over Q2, but still down from the mergers & acquisitions (M&A) boom we saw in Q3 and Q4 of 2019. Against the backdrop of a pandemic, we also saw significant developments in the approaches taken by the Federal Trade Commission (FTC) and Department of Justice (DOJ) in reviewing proposed acquisitions. The FTC has recently announced an intention to expand its retrospective analysis of consummated mergers; DOJ has restructured its merger review operations to reflect changes in how the economy operates and to allow the regulator to further specialize its review efforts; and the regulators jointly proposed amendments to the HSR premerger notification regulations that are likely to increase the number of filings required for private equity organizations.

    In Europe, as a result of the ongoing pandemic, the European Commission (EC) received a lower number of notifications (78) compared to the same period in 2018 and 2019 (106 and 116 respectively). In August, however, the number of notifications made to the EC returned to a level that has been seen in previous years (30). That being said, in September, the number of notifications fell again (24). In terms of key cases, the EC approved the acquisition of Bombardier Transportation by Alstom. With respect to policy and legislative developments, the EC announced a new policy of accepting referrals from national competition authorities in cases where the national thresholds for notification have not been met. This new policy is expected to be implemented by mid-2021. The EC also plans to introduce changes to the merger control procedural rules with a view to bringing more deals within the ambit of the EC’s simplified procedure, and to reduce the amount of information that parties are required to provide.

    In depth
    Authors

    Jon B. Dubrow

    Partner

    Washington, DC

    Joel R. Grosberg

    Partner

    Washington, DC

    Raymond A. Jacobsen , Jr.

    Partner

    Washington, DC

    Christian Krohs, LL.M. (Aberdeen)

    Partner

    Düsseldorf, Cologne

    Stephen Wu

    Partner

    Chicago

    Lisa P. Rumin

    Partner

    Washington, DC

    More insights

  • SEC Proposes Enhanced Regulatory Oversight for Government Securities Alternative Trading Systems

    SEC Proposes Enhanced Regulatory Oversight for Government Securities Alternative Trading Systems

    ARTICLE / CLIENT ALERT

    SEC Proposes Enhanced Regulatory Oversight for Government Securities Alternative Trading Systems

    October 23, 2020

    Read time: 11 min

    Key takeaways
    Overview

    On Sept. 28, 2020, the U.S. Securities and Exchange Commission (“SEC” or the “Commission”) announced a proposal extending the requirements of Regulations ATS under the Securities Exchange Act of 1934, as amended (“Exchange Act”), to alternative trading systems (“ATSs”) that only trade U.S. government securities or repurchase and reverse repurchase agreements on government securities (“Government Securities ATSs”).[1] The proposed amendments would impose extensive new transparency and regulatory requirements on Government Securities ATSs that currently operate under an exemption provided by Regulation ATS.

    Background and Current Regulatory Framework

    Currently, an ATS that trades only government securities[2] or repurchase and reverse repurchase agreements on government securities (collectively, “Government Securities”) is exempt from registering as a national securities exchange and from complying with Regulation ATS. ATSs that trade both Government Securities and non-government securities are exempt from some provisions of Regulation ATS, but generally must comply with the regulations’ requirements.

    Since the current regulatory framework of Regulation ATS was implemented in 1998, the majority of ATSs trading Government Securities, particularly U.S. Treasury Securities[3] and Agency Securities,[4] have become increasingly electronic and complex. Currently, Government Securities ATSs closely resemble ATSs that trade NMS stocks[5] and other equity securities. The Commission believes that the increasingly electronic and complex nature of Government Securities ATSs, as well as the increased significance of Government Securities ATSs as venues for trading Government Securities, necessitate the proposed changes and increased regulatory oversight over such trading venues.

    Proposed Amendments

    The Commission is proposing to amend Regulation ATS to eliminate the exemption from compliance with Regulation ATS for those ATSs that only trade Government Securities. Specifically, Government Securities ATSs would no longer be exempt from the definition of “exchange” under Section 3(a)(1) of the Exchange Act and Government Securities ATSs would either have to register as national securities exchanges or comply with the requirements of Regulation ATS.

    Notably, banks currently may operate Government Securities ATSs without having to register as broker-dealers. Under the proposed rule change, banks operating Government Securities ATSs would have to either register as a national securities exchange or divest their ATS operations, including by, among other things, transferring such operations to a broker-dealer affiliate.[6]

    Proposed Disclosure Requirements

    Currently, the disclosure obligations of Regulation ATS vary depending on whether the ATS trades NMS stocks. Where an ATS trades NMS stocks (“NMS Stock ATSs”), the operator must file and keep current Form ATS-N, which requires public disclosures of, among other things, the ATS’ manner of operation and the operator’s policies and procedures regarding the protection of subscriber confidential information. ATSs that trade securities other than NMS stocks must file Form ATS, which requires similar, although less detailed, non-public disclosures. Where an ATS permits trading in both NMS stocks and other securities, the operator must file and keep current a Form ATS-N relating to the ATS’ NMS stock operations and a Form ATS relating to the ATS’ other operations.

    Under the proposal, the operator of a Government Securities ATS would be required to prepare and file Form ATS-G with the Commission.[7] As a general matter, Proposed Form ATS-G is largely duplicative of Form ATS-N and incorporates a large number of Form ATS-N’s disclosure items unchanged.[8] Like Form ATS-N, Form ATS-G would be publicly posted on the SEC’s website,[9] although operators of Government Securities ATSs would have to separately post their current Form ATS-G on their own website.[10] Further, the SEC’s proposal would require that operators of Government Securities ATS comply with Exchange Act rule 304 generally,[11] including the requirement to submit Updating, Material and Correcting Amendments, as applicable.[12] Form ATS-G amendments will be subject to the SEC’s current review process applicable to Form ATS-N amendments.[13]

    Accordingly, firms that currently operate an NMS Stock ATS should be largely familiar with the proposed disclosure and filing requirements that would apply to Government Securities ATSs. Nevertheless, Form ATS-G, as proposed, does include certain distinctions from Form ATS-N given the differences in the markets for NMS stocks and Government Securities, including:

    • Form ATS-G does not have an item corresponding to Part III, Item 16 (Routing) of Form ATS-N;
    • Form ATS-G does not have an item corresponding to Part III, Item 24 (Order Display and Execution Access); and
    • Form ATS-G added proposed Part III, Item 16 requiring information about non-government securities markets (g., futures, currencies, swaps, corporate bonds) used in conjunction with the ATS.

    While the SEC recognizes that “almost all requests for information on proposed Form ATS-G are similar to or derived from Form ATS-N;”[14] responses to certain items may be materially different given the differences between the two markets. For instance, while NMS Stock ATSs generally rely on market data disseminated by the national securities exchanges (whether through direct feeds or the SIP), Government Securities ATSs may rely on market data from other Government Securities ATSs and, where the Government Securities ATS allows exchange for physical (EFP) transactions, certain futures markets. Accordingly, Government Securities ATSs’ disclosures regarding “Display” and “Market Data” may be materially different from the corresponding disclosures on Form ATS-N.

    The SEC recognizes that there may be additional distinctions between the equities markets and the markets for government securities that have not been considered in the proposal. As such, market participants are encouraged to address other areas they believe might require additional, or amended, disclosures on Form ATS-G by commenting on the Commission’s proposal.

    Proposed Changes to Regulation SCI

    Regulation SCI was adopted to strengthen and safeguard the technological infrastructure of the U.S. securities markets. Regulation SCI applies to certain market participants that the Commission considers essential to the efficient functioning of the U.S. securities markets (“SCI entities”). SCI entities are required to establish, maintain and enforce written policies and procedures reasonably designed to ensure that their systems have the capacity, integrity, resiliency, availability and security adequate to maintain their operational capability and a fair and orderly market.

    When the Commission adopted Regulation SCI, fixed-income ATSs were excluded from the requirements of Regulation SCI because the fixed-income markets[15] relied much less on automation and electronic trading than the equity markets, with slower execution times and less complex routing strategies. Due to the changes in market conditions for government securities discussed above, the Commission is proposing to apply Regulation SCI to Government Securities ATSs that trade a significant volume of U.S. Treasury or Agency Securities in order to enhance the integrity and resiliency of these vital markets. Under the proposal, Regulation SCI would apply to those ATSs which, during at least four of the preceding six calendar months had: with respect to U.S. Treasury Securities, 5% or more of the average weekly dollar volume traded in the United States as provided by the SRO to which such transactions are reported; or had, with respect to Agency Securities, 5% or more of the average daily dollar volume traded in the United States as provided by the SRO to which such transactions are reported.

    The SEC, when adopting Regulation SCI,[16] noted that it had considered expanding the definition of SCI entity to include all broker-dealers (or, alternatively, certain categories of broker-dealers in addition to operators of NMS Stock ATSs), but had ultimately declined to do so. The SEC noted, however, that it would continue to assess whether Regulation SCI should be expanded to cover broker-dealers generally. As such, the proposed expansion of Regulation SCI to operators of certain Government Securities ATSs may represent an incremental step as the SEC considers expanding the requirements of Regulation SCI to broker-dealers more generally.

    Other Proposed Regulatory Changes

    Aside from the major proposals described above, the Commission also announced a number of additional proposals designed to, among other things, clarify certain requirements under Regulation ATS and enhance the disclosure obligations applicable to Form ATS. Specifically, the Release includes proposed rule changes that would:

    • Apply the Fair Access Rule to Government Securities ATSs that meet the thresholds detailed above for Regulation SCI;
    • Clarify that, for purposes of determining compliance with the Fair Access Rule, ATS’ transaction volume is calculated based on the share volume for equity securities and dollar volume for debt securities;
    • Allow Forms ATS and ATS-R to be submitted electronically through EDGAR;
    • Make public the types of securities that ATSs disclose that they trade on Forms ATS or ATS-R;
    • Require ATSs to specify whether amendments to Form ATS are “material, periodic, or correcting”; and
    • Make certain clerical and administrative changes to Form ATS-N.[17]

    Conclusion

    As a general matter, the proposed rule changes represent the expansion of current rules (e.g., Regulation SCI and the requirements applicable to NMS Stock ATSs under rule 304 of Regulation ATS) to new entities and trading venues. The Proposal recognizes that the proposed expansion, which largely takes existing requirements applicable to NMS Stock ATSs and applies them to Government Securities ATSs with minimal revision, may have failed to account for all relevant distinctions between the markets for NMS stocks and government securities. Accordingly, the SEC has invited comments from markets participants on whether, and how, the Proposal may be better tailored to Government Securities markets.

    Importantly, market participants that are ultimately subject to the proposed rules may already be largely familiar with (and subject to) the requirements of Regulations ATS and SCI, including by already filing and keeping current Form ATS-N for their equity NMS Stock ATSs. However, this expansion of existing rules, including the proposed expansion of Regulation SCI to certain Government Securities ATSs, may represent an incremental expansion as the SEC determines whether additional broker-dealers and participants should be subject to the requirements of Regulation ATS and Regulation SCI (or to rules closely modeled after these regulations).

    Comments are due within 60 days of publication of the Proposal in the Federal Register. Please contact any of the SRZ attorneys below with questions regarding this Alert.

    Authored by Julian Rainero, Derek N. Lacarrubba, David S. Sieradzki, William J. Barbera and Jacqueline Srour.


    [1] Regulation ATS for ATSs that Trade U.S. Government Securities, NMS Stock, and Other Securities; Regulation SCI for ATSs that Trade U.S. Treasury Securities and Agency Securities; and Electronic Corporate Bond and Municipal Securities Markets, Release No. 34-90019, Sept. 28, 2020 (“Proposing Release”).

    [2] The term “government securities” is defined under Section 3(a)(42) of the Exchange Act.

    [3] U.S. Treasury Securities are direct obligations of the U.S. Government issued by the U.S. Department of the Treasury (“Treasury Department”) and are the most liquid and commonly traded government securities. Securities issued by the Treasury Department include Treasury bills, nominal coupons notes and bonds, Floating Rate Notes and Treasury Inflation Protected Securities.

    [4] Agency Securities include securities issued by or guaranteed by U.S. Government corporations and U.S. Government sponsored enterprises and are generally considered to be very liquid and offer state and local tax advantages to the holder.

    [5] The term “NMS stocks” is defined under Exchange Act Rule 600(b)(48).

    [6] While there is no express prohibition on a bank registering as a broker-dealer and sponsoring an ATS, it is generally not practical.

    [7] For clarity, this could result in an ATS operator having to maintain three separate disclosure documents, (i) a Form ATS-N for the ATS’ NMS stock operations, (ii) a Form ATS-G for the ATS’ government securities’ operations and (iii) a Form ATS for the ATS’ other operations.

    [8] Form ATS-N, available here.

    [9] See Form ATS-N Filings and Information (“SEC’s ATS-N Website”) for a listing of all Form ATS-N submissions.

    [10] Currently, operators of NMS Stock ATSs must link to the SEC’s ATS-N Website, but are not separately required to post their current Form ATS-N on their websites.

    [11] The Proposing Release also contemplates certain technical amendments to Exchange Act Rule 304, including amendments designed to clarify the rule’s applicability to both NMS Stock ATSs and Government Securities ATSs.

    [12] See Exchange Act Rule 304(a)(2)(i).

    [13] See Exchange Act Rule 304(a)(2)(ii).

    [14] See Section III of the Proposing Release.

    [15] That is, the fixed-income markets generally.

    [16] See Exchange Act Release No. 34–73639 (79 Fed. Reg. 72251, Dec. 5, 2014)(“Regulation SCI Adopting Release”).

    [17] See Section V. D. of the Proposing Release.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    William J. Barbera

    Partner

    New York – 919 Third Avenue

    More insights

  • Exasperation, Frustration, Disappointment

    Exasperation, Frustration, Disappointment

    ARTICLE

    Exasperation, Frustration, Disappointment

    October 19, 2020

    Read time: 1 min

    Key takeaways
    Overview

     

     

    In depth
    Authors

    Arthur R. Rosen

    Senior Counsel

    Miami, New York – One Vanderbilt Avenue

    More insights

  • Protecting Space-Based Assets from Cyber Threats

    Protecting Space-Based Assets from Cyber Threats

    ARTICLE

    Protecting Space-Based Assets from Cyber Threats

    October 17, 2020

    Read time: 1 min

    Key takeaways
    Overview

     

     

    In depth
    Authors
    More insights

  • Regulated Funds: SEC Adopts New Rule Formalizing Fund of Funds Arrangements

    Regulated Funds: SEC Adopts New Rule Formalizing Fund of Funds Arrangements

    ARTICLE / CLIENT ALERT

    Regulated Funds: SEC Adopts New Rule Formalizing Fund of Funds Arrangements

    October 16, 2020

    Read time: 18 min

    Key takeaways
    Overview

    On Oct. 7, 2020, the U.S. Securities and Exchange Commission (“Commission”) adopted a new rule under the Investment Company Act of 1940, as amended (“1940 Act”), aimed at streamlining the regulatory framework for the investment by regulated funds in other funds (“fund of funds arrangements”).[1] Subject to complying with certain conditions, Rule 12d1-4 (“Rule”) will permit a registered investment company or a business development company (“BDC”) to acquire the securities of any other registered investment company or BDC in an amount that exceeds the limits set forth in Section 12(d)(1) of the 1940 Act, without the need for such fund to obtain exemptive relief from the Commission. The Rule, which was first proposed in December 2018, is intended to provide regulated funds with investment flexibility, while at the same time protecting investors against concerns potentially raised by fund of funds arrangements.[2]

    Notably, the Rule expands the scope of the types of regulated funds that may participate in fund of funds arrangements in excess of the Section 12(d)(1) limits, to include, for example, investments in unlisted closed-end funds and unlisted BDCs. In doing so, the Rule will eliminate unnecessary distinctions among fund types and create a more uniform framework for all registered funds and BDCs. In addition, the Rule is not exclusive, and regulated funds may continue to rely on other statutory exemptions under Section 12(d)(1), including Section 12(d)(1)(F).[3] Overall, the Rule’s streamlined approach should create opportunities for asset managers to consider launching new fund of funds products.

    Private funds, which as acquiring funds are subject to a 3% investment limit under Section 12(d)(1)(A)(i), are excluded from the Rule, and therefore cannot rely on the Rule to invest in excess of the 3% limit in a regulated fund.[4] However, as discussed below, the release of the Commission adopting the Rule (“Adopting Release”) notes that the exemptive relief process would provide an appropriate opportunity for the Commission to consider fund of funds arrangements involving private funds.

    Section 12(d)(1) Investment Restrictions

    Section 12(d)(1)(A) of the 1940 Act prohibits a regulated fund (“acquiring fund”) from acquiring securities of another regulated fund (“acquired fund”) if the acquiring fund, and any company or companies controlled by the acquiring fund, immediately after such acquisition would own (i) more than 3% of the voting securities of the acquired fund, (ii) securities issued by the acquired fund having an aggregate value of in excess of 5% of the acquiring fund’s total assets or (iii) securities issued by the acquired fund and all investment companies having an aggregate value of in excess of 10% of the acquiring fund’s total assets. Private funds are deemed to be “acquiring funds” solely for purposes of the 3% limitation on acquisitions of voting securities of acquired funds, but are not subject to the remaining restrictions set forth under Section 12(d)(1)(A). Section 12(d)(1)(B) imposes similar restrictions on the sale of securities in violation of certain limits. As noted in the Adopting Release, the provisions of Section 12(d)(1) are intended to prevent the pyramiding of fund ownership, which can result in an acquiring fund controlling the assets of an acquired fund and enriching the acquiring fund’s shareholders at the expense of the shareholders of the acquired fund.

    Overview of the Rule and Related Conditions

    Generally, the Rule will permit acquiring funds to acquire shares of other acquired funds in excess of the Section 12(d)(1) limits, subject to certain conditions, as described in more detail below. However, in practice, acquiring funds will be limited to acquiring up to 25% of an acquired fund’s shares, due to the prohibition on controlling an acquired fund, except in certain limited circumstances. The Rule will also provide an exemption from the affiliated transaction provisions contained in Section 17(a) of the 1940 Act to permit an acquiring fund to hold 5% or more of an acquired fund’s securities.[5]

    Limits on Control

    In order to rely on the Rule, an acquiring fund and its “advisory group” may not acquire control over an acquired fund.[6] The 1940 Act defines control as the power to exercise a controlling influence over a company and sets up a rebuttable presumption that a person who beneficially owns more than 25% of the voting securities of a company controls such company. However, a control relationship may also be found to exist depending on the facts and circumstances of the situation, even if less than 25% of the voting securities of a company is owned. Under the Rule, assuming that the facts and circumstances do not suggest the existence of a control relationship, an acquiring fund will generally be able to invest up to 25% of the acquired fund’s shares.[7]

    Voting Requirements

    While all funds may acquire up to 25% of an acquired fund’s shares under the Rule, the Rule imposes different voting requirements on acquiring funds depending on whether the acquired fund is an open-end or closed-end fund. The Adopting Release notes that closed-end funds may be more likely to be the target of proxy contests because of annual shareholder meeting requirements, and therefore they may be more susceptible to undue influence from acquiring funds. To mitigate this potential influence, an acquiring fund and its advisory group that own more than 10% of the outstanding voting securities of an acquired closed-end fund must use mirror voting to vote the shares of such fund.[8] In addition, in the event the share ownership of an open-end fund or unit investment trust exceeds 25% (which would be expected to happen only if there was a decrease in the outstanding voting securities of the acquired fund), the acquiring fund and its advisory group likewise would be required to mirror vote their shares of the acquired fund. These voting thresholds differ from the thresholds initially proposed, which would have required mirror voting at a much lower 3% threshold.

    Required Findings

    A key aspect of the Rule is a requirement that the investment advisers of acquired funds and acquiring funds that are management companies[9] make certain findings intended to alleviate potential concerns of undue influence by acquiring funds in fund of funds arrangements.[10] An acquired fund’s investment adviser will be required to assess, at a minimum, the following factors enumerated in the Rule in order to make a finding that any undue influence concerns associated with an investment by an acquiring fund are reasonably addressed:

    • The scale of contemplated investments by the acquiring fund and any maximum investment limits;
    • The anticipated timing of redemption requests by the acquiring fund;
    • Whether and under what circumstances the acquiring fund will provide advance notification of investments and redemptions; and
    • The circumstances under which the acquired fund may elect to satisfy redemption requests in kind rather than in cash and the terms of any such redemptions in kind.[11]

    An acquiring fund’s investment adviser similarly will be required to make a finding that the acquiring fund’s fees and expenses do not duplicate the fees and expenses of the acquired fund, based on an evaluation of the complexity of the structure and the fees and expenses associated with the acquiring fund’s investment in the acquired fund.[12] These findings must be made prior to investment by an acquiring fund in an acquired fund in reliance on the Rule. In addition, the investment adviser to an acquiring fund will be required to report on its evaluation and finding to the board of directors of the acquiring fund.

    While the rule as proposed would have required an acquiring fund’s investment adviser to make a determination that the investment was in the “best interest of the acquiring fund,” the Adopting Release notes that this standard could be unclear or overly broad, and the Rule as adopted instead focuses on an evaluation of the complexity and fees and expenses of the fund of funds arrangement. Certain other differences between the proposed rule and the Rule as adopted include the requirement for the acquired fund findings and the required timing and frequency for making the findings and reporting to the board of directors. Under the Rule, an investment adviser will be required to report the applicable findings to the board one time, at the next regularly scheduled board meeting, with ongoing reporting conducted pursuant to the fund’s compliance program in connection with Rule 38a-1 under the 1940 Act.

    Fund of Funds Investment Agreement

    The Rule will require funds that do not have the same investment adviser to enter into a fund of funds investment agreement prior to acquisition by an acquiring fund of the securities of the acquired fund in excess of the Section 12(d)(1) limits. The agreement is intended to provide the funds an opportunity to negotiate, memorialize and provide for enforcement of the terms governing the arrangement. This requirement aims to prevent undue influence over an acquired fund, particularly in the form of the threat of large-scale redemptions by an acquiring fund, and to provide notice to an acquired fund of the investment by an acquiring fund in reliance on the Rule. The fund of funds investment agreement entered into by the acquiring and acquired funds may be tailored to the funds’ circumstances, but at a minimum must include the following provisions:

    • Any material terms regarding the acquiring fund’s investment in the acquired fund necessary to make the finding required by the Rule;
    • A termination provision whereby either the acquiring fund or acquired fund may terminate the agreement subject to written notice no longer than 60 days in advance; and
    • A requirement that the acquired fund provide the acquiring fund with information on the fees and expenses of the acquired fund reasonably requested by the acquiring fund.[13]

    The Adopting Release reminds investment advisers that in negotiating this agreement, advisers must ensure compliance with legal and regulatory requirements under the Federal securities laws. In addition, a fund of funds investment agreement must be filed as an exhibit to the funds’ registration statements. As noted above, funds with the same primary investment adviser do not need to enter into a fund of funds investment agreement, but the agreement will be required where an investment adviser serves as an adviser to one fund and a sub-adviser to the other fund, or as sub-advisers to both funds. Advisers to both an acquiring and acquired fund also must act in accordance with their fiduciary duties to each fund.

    Limitations on Complex Structures

    The Rule will generally limit fund of fund arrangements to two-tier structures (i.e., one acquiring fund and one acquired fund), due to the potential for excessive fees and investor confusion posed by multi-tier arrangements. However, the Rule does contain certain limited exceptions, including an exception to allow an acquired fund to invest up to 10% of its total assets in other investment companies or private funds, without any restriction on the size of the investment in any one fund.[14] This 10% exception is intended to provide portfolio management flexibility for funds, while continuing to prevent unnecessarily complex arrangements. The Adopting Release also acknowledges that certain existing multi-tier fund structures may be required to modify their investments in order to comply with the Rule.

    Other Provisions of the Rule and Related Changes

    Rescission of Rule 12d1-2

    In connection with the adoption of the Rule, the Commission is rescinding Rule 12d1-2, which provides flexibility to funds relying on Section 12(d)(1)(G) to invest in other types of securities.[15] This will limit a fund relying on Section 12(d)(1)(G) from acquiring securities of other funds that are not part of the same group of investment companies and from investing directly in securities, except in compliance with the Rule. However, the Commission is also amending Rule 12d1-1 in order to permit funds relying on Section 12(d)(1)(G) to invest in money market funds outside the same group of investment companies in reliance on that rule.

    Rescission of Exemptive Orders and Withdrawal of No-Action Letters

    The Commission is also rescinding all orders granting exemptive relief from Sections 12(d)(1)(A), (B), (C) and (G), with certain limited exemptions, as well as rescinding the relief relating to Sections 12(d)(1)(A) and (B) contained in exemptive orders for exchange-traded funds (“ETFs”). Fund of funds exemptive relief that is outside the scope of the Rule will remain in place. No-action letters issued by the staff of the Division of Investment Management of the Commission (“Staff”) stating that the Staff would not recommend an enforcement action relating to Section 12(d)(1), except those falling outside the scope of the Rule, will also be withdrawn.

    Amendment to Form N-CEN

    Form N-CEN, which requires registered funds to provide census-type information to the Commission on an annual basis, will be amended to require a management company relying on the Rule or on Section 12(d)(1)(G) to disclose such information in the form.

    Recordkeeping Requirements

    The Rule will require acquired and acquiring funds relying on the Rule to maintain the certain documentation, including copies of fund of funds investment agreements, records of the findings made by investment advisers and records of the applicable evaluations supporting such findings.

    Compliance Dates

    The rescission of Rule 12d1-2, the rescission of exemptive relief, the withdrawal of no-action letters and the amendment to Form N-CEN in connection with the Rule will be effective one year after the effective date of the Rule.

    Impact of the Rule on Regulated Fund Boards and Advisers

    As previously noted, the Rule represents an effort by the Commission to formalize and codify positions previously established by the Commission through exemptive orders and reflects the ongoing efforts by the Commission and the Staff to streamline the requirements applicable to regulated funds. In providing a consistent framework for the formation and regulation of fund of funds arrangements under the 1940 Act, regulated funds and their advisers should benefit from the certainty provided by the Rule. Certain regulated funds will find that their existing investment structures will require modification, and the Rule will require additional effort on the part of advisers and regulated fund boards to evaluate proposed fund of funds arrangements and make appropriate findings. However, regulated funds should benefit overall from a coherent approach to fund of funds arrangements provided by the Rule. In particular, the Rule will ease the process for launching new fund of funds structures, in a manner similar to the Commission’s recent efforts to streamline exemptions applicable to ETFs, which may in turn lead additional asset managers to consider launching new fund of funds products.

    Impact of the Rule on Private Funds

    The Rule extends only to regulated funds and, therefore, excludes reliance by private funds. As a result, unlike regulated funds, private funds are unable to rely on the Rule to permit acquisitions of regulated fund securities in excess of the 3% ownership limit set forth in Section 12(d)(1)(A)(i) under the 1940 Act. Notably, however, the Commission opted not to issue guidance on the application of the 3% ownership limitation to private funds that share a common adviser, despite numerous commenters urging the Commission to do so as part of its rule-making process. As a result, the 3% ownership limitation under Section 12(d)(1)(A)(i) applicable to private funds will continue to be applied on a fund-by-fund basis, with no aggregation between such private funds even when managed by the same adviser.

    The Adopting Release does not rule out the possibility of future rulemaking in this area applicable to private funds, but indicates that, for the time being, the exemptive order application process would be the appropriate channel for further consideration by the Commission of fund of funds arrangements involving private funds (though exemptive relief has not previously been granted to permit a private fund to exceed the Section 12(d)(1) limit). The Adopting Release notes that providing relief through the exemptive process to private funds wishing to exceed the 3% investment limit would permit the Commission to design appropriate conditions, limitations and reporting requirements, while allowing the Commission and the Staff to monitor and analyze the impact of fund of fund arrangements involving private funds, prior to considering any future rulemaking. The Adopting Release also encourages interested parties to contact the Staff of the Division of Investment Management with any input on these types of arrangements involving private funds.

    Authored by Karen Spiegel and Noah B. Aschen.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] Investment Company Act Release No. 34045 (Oct. 7, 2020), available here.

    [2] Investment Company Act Release No. 33329 (Dec. 19, 2018), available here. The rule as adopted is generally consistent with the proposed rule, with the exception of a few material changes discussed herein, including the removal of a limitation on redemptions by acquiring funds.

    [3] Section 12(d)(1)(F) generally exempts acquisitions of securities by a regulated fund from the applicable provisions of Section 12(d)(1) so long as (i) immediately after such acquisition not more than 3% of the total outstanding stock of the issuer of such securities is owned by the acquiring regulated fund and all affiliated persons of such regulated fund, and (ii) such regulated fund has not sold securities through a principal underwriter with a sales load above certain specified thresholds. In addition, the acquiring regulated fund must either seek instructions from its own shareholders with respect to any proxies for such securities, or otherwise mirror vote such securities.

    [4] In declining to include private funds in the scope of the Rule, the release adopting the Rule notes that private funds are not required to provide the Commission with the same level of reporting as registered funds, which would be necessary in order to monitor proper compliance with the Rule. In addition, private funds are not subject to 1940 Act governance and compliance requirements which can help to minimize conflicts of interest that may be present in a fund of funds arrangement.

    [5] Without such an exemption, an acquiring fund holding 5% or more of an acquired fund’s securities would be considered an affiliated person of the acquired fund and the funds would be prohibited under Section 17(a) from engaging in any further transactions, including making additional investments or redemptions. Under the Rule, BDCs will be exempted from analogous provisions under Section 57(a) of the 1940 Act.

    [6] Advisory group is defined in the Rule as “(1) An acquiring fund’s investment adviser or depositor, and any person controlling, controlled by, or under common control with such investment adviser or depositor; or (2) An acquiring fund’s investment sub-adviser and any person controlling, controlled by, or under common control with such investment sub-adviser.” The Adopting Release acknowledges that the broad definition of advisory group may involve increased compliance and monitoring efforts by acquiring funds and other members of the advisory group. The Adopting Release also notes that the definition of advisory group does not, however, include funds managed by unaffiliated subadvisers.

    [7] Where an acquiring fund is part of the same “group of investment companies” (i.e., registered funds or BDCs that hold themselves out to investors as related companies for investment and investor services) as the acquired fund, or where an acquiring fund’s investment sub-adviser acts as the acquired fund’s investment adviser, the control limitations, as well as the voting limitations described below, do not apply.

    [8] Mirror voting entails voting in a manner that is proportionate to the vote of all other shareholders of the acquired fund. The Rule also requires that in the event mirror voting is not feasible (for example, because all of the investors in an acquired fund are acquiring funds investing pursuant to the Rule), the acquiring fund must pass through its vote to its underlying shareholders.

    [9] The Rule’s requirements differentiate between management companies (which include BDCs) and Unit Investment Trusts (“UITs”). While acquiring UITs are subject to certain findings requirements as described in the Adopting Release, because UITs are unmanaged they do not face the same undue influence concerns as management companies, and therefore UITs that are acquired funds are not required to make any findings. The Rule also contains certification requirements for separate accounts funding variable insurance contracts.

    [10] This requirement, along with the requirement to enter into fund of fund investment agreements, takes the place of the redemption limitation and disclosure requirements originally included in the proposed rule, which would have required that an acquiring fund owning more than 3% of an acquired fund’s shares not redeem more than 3% of the shares in any 30-day period. The proposed rule also would have required that a fund disclose in its registration statement its status as an acquiring fund. The Adopting Release notes several concerns raised by commenters opposing both the redemption limits and disclosure requirement, including that such redemption limits could negatively impact the ability of acquiring funds to achieve their investment objectives and could present significant operational and administrative challenges.

    [11] Rule 12d1-4(b)(2)(i)(B). The Adopting Release notes that any other relevant regulatory requirements must be considered in addition to these factors.

    [12] Rule 12d1-4(b)(2)(i)(A). The Adopting Release also notes the existing responsibility of an acquiring fund’s board of directors to evaluate the terms of the acquiring fund’s advisory agreement, including fees, pursuant to Section 15(c) of the 1940 Act, as well as the fiduciary duty of advisers with respect to the receipt of compensation pursuant to Section 36(b). An investment adviser to an acquiring fund must therefore be cognizant of the services it is providing to the acquiring fund, as opposed to services that are being performed by the adviser to the acquired fund, and ensure that fees of the acquiring fund are structured appropriately.

    [13] Rule 12d1-4(b)(2)(iv)(A).

    [14] Certain multi-tier arrangements will be permissible, including master-feeder arrangements pursuant to Section 12(d)(1)(E) and acquisitions pursuant to Rule 12d1-1.

    [15] Section 12(d)(1)(G) permits open-end funds and UITs to purchase an unlimited amount of shares of other open end funds and UITs in the same group of investment companies in excess of the limits of Section 12(d)(1), subject to certain conditions.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors
    More insights

  • National Telehealth Takedown Highlights Opportunity for Providers to Enhance Compliance Efforts

    National Telehealth Takedown Highlights Opportunity for Providers to Enhance Compliance Efforts

    ARTICLE / CLIENT ALERT

    National Telehealth Takedown Highlights Opportunity for Providers to Enhance Compliance Efforts

    October 14, 2020

    Read time: 9 min

    Key takeaways
    Overview

    The US Department of Justice and the US Department of Health and Human Services Office of Inspector General recently announced a significant healthcare fraud takedown involving $4.5 billion in allegedly false and fraudulent claims involving telehealth. The allegations involved telehealth executives paying healthcare providers to order unnecessary items and services, as well as payments from durable medical equipment companies, laboratories and pharmacies for those orders. While the alleged conduct is not representative of the legitimate and crucial telehealth services offered by the vast majority of healthcare providers, the government’s continued focus on telehealth arrangements, combined with the ongoing expansion of coverage for telehealth services, provides an important opportunity for healthcare providers to evaluate their telehealth service offerings and arrangements and to further enhance their related compliance activities.

    In depth

    On September 30, 2020, the US Department of Justice (DOJ) issued a press release describing the largest national healthcare fraud and opioid enforcement action in the DOJ’s history (the Takedown). The Takedown involved coordination with the US Department of Health and Human Services Office of Inspector General (OIG) and other federal and state law enforcement agencies, and resulted in cases against more than 345 defendants in 51 judicial districts. The government charged the defendants with participating in healthcare fraud schemes involving more than $6 billion in alleged losses to federal health care programs, with the vast majority of alleged losses ($4.5 billion) stemming from arrangements involving alleged “telefraud.”

    According to the DOJ press release, a recently announced National Rapid Response Strike Force led the initiative focused on telehealth. The National Rapid Response Strike Force is part of the Health Care Fraud Unit of DOJ’s Criminal Division Fraud section, and its mission is to “investigate and prosecute fraud cases involving major health care providers that operate in multiple jurisdictions, including major regional health care providers operating in the Criminal-Division-led Health Care Fraud Strike Forces throughout the United States.”

    Background

    In recent years, the government has increasingly focused on alleged healthcare fraud schemes involving telehealth services. In connection with the Takedown, OIG issued a fact sheet and graphic highlighting the increase in “telefraud” arrangements leveraging “aggressive marketing and so-called telehealth services.” The individuals charged in the Takedown included telehealth company executives, medical providers, marketers and business owners who allegedly used telemarketing calls, direct mail, and television and internet advertisements to collect information from unsuspecting patients.

    Many of the cases involved telehealth executives who allegedly paid healthcare providers to order unnecessary durable medical equipment (DME), genetic and other diagnostic testing, and medications, either without any patient interaction or with only a brief phone call. The government alleged that the arrangements involved kickbacks to telehealth executives after the DME company, laboratory or pharmacy billed Medicare or Medicaid for items and services that the government asserts were often not provided to beneficiaries or were “worthless to patients . . . and delayed their chance to seek appropriate treatment for medical complaints.”

    DOJ provided a summary of the cases prosecuted, which included a wide variety of alleged fraudulent schemes involving telehealth, including the following:

    • A marketing company that recruited Medicare beneficiaries to obtain medically unnecessary genetic testing ordered by telehealth physicians who received illegal kickbacks and bribes from telehealth companies.
    • An owner and operator of a telehealth company who paid kickbacks and bribes to call centers and healthcare professionals in exchange for referrals and orders for medically unnecessary genetic cancer screening tests for Medicare beneficiaries.
    • A laboratory owner who conspired to pay kickbacks for genetic testing orders and specimens to run medically unnecessary diagnostic testing.
    • Laboratory owners who were charged with paying kickbacks to a network of marketers to procure DNA samples for genetic testing that they knew to be medically unnecessary and not reimbursable by the patients’ health care benefit programs. Beneficiaries were solicited through methods such as telemarketing, door-to-door sales and appearances at senior health fairs, and the tests were approved by a range of medical professionals, including doctors operating on telehealth platforms, who had not previously treated the patients and had little or no contact with the patients in connection with prescribing the testing.

    Practical Implications

    The Takedown is an example of the government’s continued and growing focus on telehealth services arrangements. Although the alleged fraudulent practices are not representative of the broader community of telehealth providers that deliver necessary care to patients in a convenient and efficient way, the government’s actions offer insights that can help legitimate telehealth providers further enhance their ongoing compliance practices. As telehealth becomes an increasingly common method for delivering healthcare, current telehealth providers and those organizations considering expanding into telehealth services, as well as individual healthcare providers who may provide telehealth services through another company, should consider the following issues when reviewing their existing telehealth programs or before establishing a new telehealth service line or entering into arrangements with third parties to provide telehealth services.

    Patient-Provider Relationship. Two common features of many of the Takedown cases, according to DOJ, were the lack of meaningful interaction between provider and patient and the ordering of medically unnecessary products or services. These cases often involved alleged inappropriate patient marketing activities where a potential patient received a “cold call” followed by a telephonic examination if the potential patient expressed a willingness to speak to a provider. The requirements for establishing a sufficient patient-provider relationship for diagnosis, treatment, and the ordering of medical equipment and laboratory testing are determined primarily by state laws and regulations. These laws and regulations may be unclear on the types of technology modalities required to conduct a patient examination that supports the issuance of a prescription or order. In addition to complying with state law requirements, a valid patient-provider relationship is typically required to bill payors for telehealth services. Identifying the sometimes blurry line between appropriate and inappropriate conduct is critical to ensuring that appropriate care is delivered and to mitigating legal risk.

    Employee Moonlighting. Provider organizations should consider evaluating any “moonlighting” activities by their employed or contracted providers. In light of the Coronavirus (COVID-19), many physicians and other providers are seeking additional opportunities to provide care to patients because of the sharp decline in in-person visits. Providers may begin providing telehealth services through other companies or entities during their “off” hours. These providers should ensure that they engage with reputable telehealth companies to avoid getting caught up in the types of alleged telefraud arrangements that were the focus of the Takedown. Provider organizations should understand what their physicians are doing outside of their regular jobs; if a physician is unknowingly participating in a potentially fraudulent telehealth arrangement, that could negatively affect the provider organization’s reputation. Provider organizations that permit their employed and contracted staff to “moonlight” can help mitigate risk by offering education and resources to individual providers to ensure they are aware of the existence of fraudulent telehealth companies and networks that may not have the providers’—or their patients’—best interests in mind.

    Coverage and Billing Requirements. Increasing recognition of the value and benefits of telehealth is resulting in the rapid evolution of coverage and billing requirements for telehealth services. While these changes can positively affect a telehealth program’s operations, organizations should carefully review and stay up-to-date on government and commercial payor requirements for telehealth services, as they are not always as broad or liberating as they may first appear. Organizations should ensure that appropriate checks are in place to make certain that they use proper billing and reimbursement codes.

    COVID-19 Waivers and Their Eventual Expiration. During the COVID-19 public health emergency, the Centers for Medicare and Medicaid Services (CMS) expanded payment for telehealth under its 1135 waiver authority and permitted providers to use dozens of new billing codes for telehealth services. Telehealth regulations have also been relaxed at the state level, as we previously detailed here and here. This rapid regulatory change has allowed more flexibility for providers and improved access to telehealth services for patients during the COVID-19 pandemic. Despite these changes, legitimate telehealth providers should develop medically appropriate clinical protocols to govern care provided via telehealth, ensure the use of safe and secure technology, and establish operating guidelines to ensure care is provided consistent with all state and federal requirements. In addition, the COVID-19-related emergency declarations that allow for these changes will end, and providers should be prepared to comply with pre-pandemic laws and regulations.

    State Licensure. In order to legitimately provide and bill for telehealth services, providers should be licensed to practice their respective profession in the state in which the patient is located at the time of the encounter, unless an exception exists. In response to COVID-19, many states have waived or loosened the licensure requirements.

    Key Takeaways
    Telehealth providers should:

    • Carefully consider the implications before entering into an arrangement with other parties, including DME companies, laboratories and pharmacies, and contemplate what different parties will provide in connection with the arrangement.
    • Be particularly diligent in the design and compliance oversight of marketing strategies to confirm that patients are reached through appropriate channels, which may not include “cold calls.”
    • Ensure that state-level requirements to establish a legitimate physician-patient relationship are satisfied. This involves evaluating the proposed arrangement under applicable state laws and regulations. Many of these laws and regulations have changed in light of COVID-19.
    • Ensure that the provider’s compliance program appropriately addresses issues brought up by telehealth arrangements, including careful review of marketing materials and compensation and billing arrangements.
    • Carefully evaluate coding and billing practices to ensure such practices are consistent with both government and commercial payor requirements. Again, these requirements have changed considerably because of COVID-19 and likely will continue to evolve.

    Please do not hesitate to contact your regular McDermott lawyer or any of the authors of this On the Subject if you have questions or need assistance with structuring and evaluating telehealth arrangements and related compliance practices and issues.

    Authors

    James A. Cannatti III

    Partner

    Washington, DC

    Marshall E. Jackson , Jr.

    Partner

    Washington, DC

    Tony Maida

    Partner

    New York – One Vanderbilt Avenue

    Lisa Mazur

    Partner

    Chicago

    Caroline Reignley

    Partner

    Washington, DC

    More insights

  • Considerations for Remote and In-Person Workers as School Year Commences

    Considerations for Remote and In-Person Workers as School Year Commences

    ARTICLE

    Considerations for Remote and In-Person Workers as School Year Commences

    October 14, 2020

    Read time: 1 min

    Key takeaways
    Overview

     

     

    In depth
    Authors

    Pankit J. Doshi

    Partner

    San Francisco, Silicon Valley

    More insights

  • Amendments to New York City’s Paid Safe and Sick Leave Law

    Amendments to New York City’s Paid Safe and Sick Leave Law

    ARTICLE / CLIENT ALERT

    Amendments to New York City’s Paid Safe and Sick Leave Law

    October 13, 2020

    Read time: 5 min

    Key takeaways
    Overview

    On Sept. 28, 2020, Mayor de Blasio signed Int. No. 2032-A into law amending New York City’s Paid Safe and Sick Leave Law (“NYC Sick Leave Law”). The changes to the NYC Sick Leave Law took effect Sept. 30, 2020, unless otherwise specified below.

    The amount of permitted safe and sick leave that must be provided to employees in New York City was amended to conform to the accrual and use provisions of New York State’s new paid sick leave law (“State Sick Leave Law”), also effective Sept. 30, 2020. Employers must provide notice to employees of the changes under the NYC Sick Leave Law within 30 days of the effective date (no later than Oct. 30, 2020).

    Employers in New York City under both State and City law will be required to provide safe and sick leave in varying amounts depending on the size of the employer, as follows:

    • Employers with four or fewer employees and a net income of less than $1 million in the prior tax year will be required to provide employees with up to 40 hours of unpaid safe and sick leave per year;
    • Employers with between five and 99 employees and employers with four or fewer employees and a net income of greater than $1 million in the prior tax year will be required to provide each employee with up to 40 hours of paid safe and sick leave per year; and
    • Employers with 100 or more employees will be required to provide up to 56 hours of paid safe and sick leave per year.

    Under the amended NYC Sick Leave Law, leave amounts greater than the amount previously provided by the NYC Sick Leave Law begin to accrue on Sept. 30, 2020, but employees cannot use such additional accrued leave until Jan. 1, 2021, which is consistent with the State Sick Leave Law. The prior NYC requirements that an employee must work 80 hours within NYC to be eligible for safe and sick leave and that newly hired employees must wait 120 days to be able to utilize accrued leave have been removed.

    Employees who are exempt from New York overtime requirements are assumed to work 40 hours in each work week for purposes of safe/sick time unless their regular work week is less than 40 hours, in which case safe/sick time accrues based upon that regular work week.

    The amended law also includes the following other new requirements that will require most employers to review and update their sick leave policies and practices accordingly.

    Notice Requirements

    The amended NYC Sick Leave Law provides that “[t]he amount of sick/safe time accrued and used during a pay period and an employee’s total balance of accrued safe/sick time shall be noted on a pay statement or other form of written documentation provided to the employee each pay period.” Moreover, notice shall be conspicuously posted at the employer’s place of business in an area accessible to employees. Samples of notices have not been updated as of this writing, but are expected to be posted in various languages.

    Expansion of “Adverse Action” Definition

    The amended NYC Sick Leave Law specifically delineates prohibited “adverse actions” that employers are prohibited from taking in response to employees’ use or attempted use of sick and safe leave. For example, the law now provides that in addition to the commonly understood “adverse actions,” such as discipline, “blacklisting” and “the maintenance or application of an absence control policy that counts protected leave for safe/sick time as an absence” could be considered “adverse actions” as well. Moreover, “[a]dverse actions include actions related to perceived immigration status or work authorization.”

    Reimbursements Associated with Required Documentation

    Employers that require employees to submit documentation verifying the need to use sick/safe time for three or more consecutive days must now reimburse such employees for any associated cost charged by their health care provider or other service provider.

    Enforcement

    Although the amended law does not create a private cause of action for individual employees, it grants the City the ability to bring civil litigation in court for pattern or practice violations of the law, or to enforce an administrative order issued pursuant to the NYC Sick Leave Law’s enforcement mechanisms.

    The NYC Sick Leave Law also provides that the City will have the power to impose penalties against any person (not just the employer) and grant “each and every” employee appropriate relief. Such “penalties shall be imposed on a per employee basis.”

    Recordkeeping

    All New York State employers are now required to maintain records on the amount of sick leave provided to each employee, in addition to other payroll information, for a minimum of six years.

    Authored by Mark E. Brossman, Ronald E. Richman, Scott A. Gold and Michelle M. Orge.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2020 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Michelle M. Orge

    Associate

    New York – 919 Third Avenue

    More insights